Address
Lux Capital Management
295 Madison Avenue
24th Floor
New York, NY 10017
United States
Phone
Website
Recent investment activity
KANDO id: 3552
Corporate information
Registration country
Company type
Research-driven investment firm focused on founding, seed and early stage investments in the physical and life sciencesFunds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| Lux Ventures V LP | Venture | 2017 | USD | 400,000,000 |
| Lux Ventures IV LP | Venture | 2015 | USD | 350,000,000 |
| Lux Ventures Cayman III LP | Venture | 2012 | ||
| Lux Ventures III Special Founders Fund LP | Venture | 2012 | ||
| Lux Ventures III LP | Venture | 2011 | USD | 245,000,000 |
Funding rounds
Investment preferences
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 63| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Atair Aerospace Inc | N/A | ||||
|
|
Cerulean Pharma Inc | Series D | ||||
|
|
Cerulean Pharma Inc | Series C | ||||
|
|
Cerulean Pharma Inc | Series B | ||||
|
|
Cerulean Pharma Inc | Series A | ||||
|
|
Everspin Technologies Inc | N/A | ||||
|
|
Genocea Biosciences Inc | Series B | ||||
|
Gridco Systems Inc | Provider of grid infrastructure solutions for electric power distribution system operators. | N/A | |||
|
|
Kereos Inc | Kereos, Inc. develops targeted molecular imaging agents and therapeutics designed to detect and treat cancer and cardiovascular disease. | N/A | |||
|
Kurion | Kurion combines robots and breakthrough chemical engineering to eliminate nuclear waste. | N/A | |||
|
|
Kymeta | Kymeta uses the physics of metamaterials to make satellite antennas as thin as paper. | N/A | |||
|
|
Magen BioSciences Inc | N/A | ||||
|
|
Transphorm Inc | A redefined power conversion company. | Series C | |||
|
|
Visterra Inc | A biotechnology company discovering and developing innovative products that will transform the prevention and treatment of infectious diseases. | Series A | |||
|
|
3Scan Inc | Developer of ultra-high resolution, 3D brain scans and digital organ reconstruction. | N/A Initial investment | |||
|
|
Accelergy Corp | N/A | ||||
|
Alluvium Inc | Developer of software that applies machine learning to mechanical data. | Seed led the round | |||
|
Anchorage Hold LLC (Anchorage Digital), (Anchorage) | Crypto-native digital asset custodian that uses modern security engineering to help institutions safeguard their assets. | Series D Initial investment | |||
|
|
Angstrom Publishing | N/A | ||||
|
Applied Intuition | Autonomous vehicle simulation. | Series B | |||
|
|
Applied Intuition | Autonomous vehicle simulation. | Series A Initial investment | |||
|
Auris Surgical Robotics Inc | Venture Follow-on investment | ||||
|
Cambrios Technologies Corp (Cambrios Advanced Materials) | Developer of proprietary nanostructured electronic materials for the display industry | Series D Initial investment | |||
|
|
Cambrios Technologies Corp (Cambrios Advanced Materials) | Developer of proprietary nanostructured electronic materials for the display industry | Series B | |||
|
|
Cambrios Technologies Corp (Cambrios Advanced Materials) | Developer of proprietary nanostructured electronic materials for the display industry | Series A |
Team
| Employee | Position | |||
|---|---|---|---|---|
| Peter Hébert (founder) | [email protected] | |||
| Robert Paull (founder) | Managing Partner (past)
|
[email protected] | ||
| Josh Wolfe (founder) | [email protected] | |||
| Tuvia Barak | ||||
| Shahin Farshchi | [email protected] | |||
|
Adam Goulburn | Partner
From |
[email protected] | |
| Zack Schildhorn | [email protected] | |||
| Mike Sims | ||||
| Bilal Zuberi | ||||
| Richard Foster | ||||
| R. James Woolsey |